Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Xenobiotic Agent
30%
Mouse
27%
Choline
26%
Methionine
23%
Effusion
21%
Pharmacokinetics
18%
Elimination
15%
Adverse Drug Reaction
14%
Drug Metabolism
12%
Nutritional Deficiency
12%
Disease
11%
Liver Disease
10%
Cholestasis
10%
Paracetamol
9%
Cytochrome P450
9%
Lipopolysaccharide
9%
Lithocholic Acid
9%
Polypeptide
9%
Mouse Model
8%
Constitutive Androstane Receptor
8%
Multidrug Resistance-Associated Protein 2
8%
Organic Anion Transporter 1
8%
Liver Injury
7%
Drug Metabolizing Enzyme
7%
Organic Anion Transporter
7%
Drug Transport
7%
Disease Exacerbation
7%
Bile Acid
7%
Fatty Liver
6%
Glucuronosyltransferase
6%
Nucleoside Analog
6%
Multidrug Resistance Protein 5
6%
Sulfotransferase
6%
Hepatoprotection
6%
Solute Carrier Organic Anion Transporter 1B2
6%
Pravastatin
6%
Equilibrative Nucleoside Transporter
6%
Permethrin
6%
Organic Anion Transporter 4
6%
Chronic Liver Disease
6%
Transcription Factors
5%
Multidrug Resistance Associated Protein 4
5%
Steatosis
5%
Multidrug Resistance Protein 3
5%
Glucuronide
5%
Keyphrases
Nonalcoholic Steatohepatitis
26%
Non-alcoholic Fatty Liver Disease (NAFLD)
18%
Liver
15%
Transporter Expression
14%
Kidney
11%
Choline-deficient
11%
Adverse Drug Reaction
10%
Organic Anion Transporter
10%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
9%
Drug Transporters
8%
Mouse Liver
8%
Methionine
8%
Bile Duct Ligation
8%
MRNA Level
7%
Multidrug Resistance-associated Protein 2 (MRP2)
7%
Mouse Model
6%
MRP3
6%
Oatp1b2
6%
Oltipraz
6%
Constitutive Androstane Receptor
6%
Acetaminophen
6%
Multidrug Resistance Protein 3 (MDR3)
6%
Intrahepatic Cholestasis
6%
Hepatocytes
6%
Glucuronide
5%
Stilbene Oxide
5%
NQO1
5%
Cholestasis
5%
